Brown’s Gas in Medicine: An Addendum
Thomas Lee Abshier, ND | 13 November 2026
Why an Addendum
In my earlier essay on Brown’s Gas, I worked through George Wiseman’s 1995 manual and concluded that Brown’s Gas is real and useful oxyhydrogen. It is hydrogen and oxygen made on demand from water in the exact 2:1 ratio. Its dramatic torch behaviors have ordinary explanations, and it does not contain hidden energy.
Since then I have listened to a long interview Wiseman gave on Mike Adams’s Decentralize TV. Much of it repeats the book. Three things are new, and they matter enough to address:
- Wiseman has replaced his old theory of “monatomic” hydrogen and oxygen with a new one. He now says Brown’s Gas contains a third component, “electrically expanded water,” which he describes as a negatively charged cold-plasma form of water.
- His main focus has moved from torches and fuel savers to health. He now sells a home Brown’s Gas machine for inhalation, priced at about $3,000.
- He made a series of medical claims, from relief of carpal tunnel pain within minutes to the complete disappearance of cancers.
This addendum is written for naturedox.com, because the medical claims are where the stakes are highest. Here a wrong belief does not cost someone a tank of gas. It can cost a patient his life.
My position: I stand on the side that inhaled hydrogen is a legitimate, low-toxicity therapeutic gas with real but still early human evidence. Brown’s Gas is a simple and inexpensive way to produce it, and I consider it a reasonable adjunct for many conditions. The specific claims that set Brown’s Gas apart in this interview are a different matter. These include a special third gas, therapeutic superiority over plain hydrogen, a “hydrogen deficiency” behind chronic disease, and cures of cancer. They are unproven, and some are contradicted by measurement. One of them, the idea that Brown’s Gas can replace cancer treatment, could cost someone his life.
Wiseman’s Story Deserves to Be Heard
I want to begin where the interview is strongest, which is with the man himself. Wiseman grew up in a trapper’s cabin in British Columbia with no electricity. He makes his living by publishing his inventions rather than patenting them. In the interview he described caring around the clock for his late wife, who died of lupus in 2016. He spoke of the grief afterward, when his body seemed to be shutting down. He set up his own machine to inhale the gas, filmed himself in case something went wrong, and kept going. He reports that his psoriasis shed, his vitality returned, and over the following year his tinnitus, arthritis, neuropathy, old scars, and a childhood heart murmur all resolved.
He also told of the day, three months later, when a woman wrote that her lupus symptoms had cleared. He said he collapsed to the floor and wept, believing his wife might have lived if he had thought to inhale the gas years earlier. He now regards his work as a way to honor her death.
I take that testimony seriously as a human account and as a clinical lead. A man’s report of his own body deserves respect. Nothing I say below is meant to diminish what he went through or what he experienced. But testimony tells us what happened to one person. It cannot tell us why it happened, or whether the same thing will happen to the next person. That requires a different kind of evidence, and those who suffer most are the ones most entitled to it.
What the Medical Research Actually Shows
The serious science of hydrogen medicine began in 2007. A Japanese team reported in Nature Medicine that rats breathing low concentrations of hydrogen suffered markedly smaller strokes. They traced the effect to hydrogen’s ability to neutralize the most destructive oxygen radicals — the hydroxyl radical and peroxynitrite — while leaving the useful signaling molecules alone. Hundreds of animal studies followed, with consistent benefit in ischemia-reperfusion injury, the damage that occurs when blood flow returns to oxygen-starved tissue.
The human evidence is smaller, but it is real:
- Cardiac arrest. The strongest human trial to date is HYBRID II, a double-blind, placebo-controlled trial at 15 Japanese hospitals. Comatose survivors of cardiac arrest received 2% hydrogen with their oxygen, or oxygen alone, for 18 hours. The primary outcome, good neurological recovery at 90 days, was 56% versus 39%, which did not reach statistical significance. Ninety-day survival was 85% with hydrogen versus 61% without, and recovery with no remaining symptoms at all was 46% versus 21%; both differences were statistically significant. The trial was stopped early because of COVID-19 and enrolled only 73 patients. It is promising, not proof.
- COVID-19 and lung disease. Chinese investigators led by Zhong Nanshan gave patients a 66% hydrogen / 33% oxygen mixture made by electrolysis of water — which is to say, Brown’s Gas — and reported better breathing and oxygen saturation. That trial was open-label and not fully randomized. A double-blind trial in chronic obstructive pulmonary disease exacerbations also reported benefit.
- Parkinson’s disease. Here the honest record is negative. A 72-week multicenter randomized trial of hydrogen water in 178 patients found no benefit. A 16-week double-blind pilot of hydrogen inhalation found it safe but without measurable effect.
- Cancer. The main human data come from a single Chinese group (Xu Kecheng and Chen Jibing). They followed 82 advanced cancer patients who inhaled the same 66/33 mixture and reported improvements in fatigue, sleep, appetite, and pain, along with falling tumor markers in about a third. They called it “real world” evidence. There was no control group, the patients were self-selected, and many received other treatments. Their published case reports of vanishing metastases are striking, but they are case reports.
Independent reviewers describe the field the same way: across a few dozen small trials, mostly from Japan and China, hydrogen is consistently safe and frequently helpful. The effects are mixed and the evidence is preliminary. That is the ground on which a responsible physician can stand. Hydrogen is a reasonable adjunct, especially where inflammation and oxidative injury drive the disease. It is not a demonstrated cure for any disease.
Where the Interview Goes Beyond the Evidence
“Electrically expanded water”
In the book, Wiseman explained Brown’s Gas as single hydrogen and oxygen atoms. In my first essay I showed why that theory fails the energy accounting. In the interview he offered a new explanation. When there is no membrane between the plates, he says, an “electron bridge” forms. Water soaks up electrons “like a sponge” and leaves the cell as a negatively charged cold plasma of unsplit water. He credits this third gas with the extra gas volume his machines produce and with roughly 30% more therapeutic benefit than plain hydrogen. Elsewhere he has said that this component does not condense when cooled.
There are three problems with this claim.
First, charge has to balance. An electrolysis cell takes in exactly as many electrons at one plate as it gives up at the other. If a stream of negatively charged gas were leaving the cell, the cell would steadily charge itself positive, and a meter between the cell and ground would show it. Electrons released into water do not wander about as a gas. They are captured in a tiny fraction of a second. “Cold plasma” is a real term, but it refers to gases kept energized by a continuous electrical discharge. It does not describe something that travels down a cannula from a box on the nightstand.
Second, there is a simpler explanation for the extra volume. Electrolyzer gas carries water vapor and fine spray, especially from a warm cell. Wiseman’s own first experiment in the book showed this most vividly: nearly all of the “gas” from his high-voltage cell turned out to be steam. A condenser and a desiccant on the output line would settle the matter in an afternoon. If the extra volume survives drying and cooling, he has something. If it disappears, it was water. And as I showed in the first essay, the “excess” figures in the Brown’s Gas literature already fit ordinary hydrogen and oxygen from an efficient cell.
Third, the claimed 30% therapeutic advantage has no published comparison behind it. Wiseman connects it to Professor Gerald Pollack’s “exclusion zone” or EZ water at the University of Washington. Pollack is a real scientist, and the exclusion-zone effect itself has been reproduced. Pollack’s theory that it is a distinct “fourth phase” of water is disputed in the literature, however; a 2020 critical review argued that diffusion effects explain the observations better. The experiment Wiseman described, in which Brown’s Gas expanded EZ water threefold and plain hydrogen did not, appears to be unpublished, and I could not find it. Even if it holds up, a larger exclusion zone in a dish is a long way from a 30% better clinical result in a patient.
The test that would settle the therapeutic question is simple and inexpensive. Run a blinded trial with three arms: Brown’s Gas from a membraneless cell, the same hydrogen-oxygen mixture from a membrane cell recombined after separation, and air. If the third gas exists and matters, the first arm will win. Until that is done, I treat the claim as a hypothesis advanced by the man who sells the machine.
“Most of us are hydrogen deficient”
Wiseman argues that the body is 62% hydrogen, that hydrogen is our most important macronutrient, and that damaged gut flora leave most people hydrogen-deficient. In his account, the body then shuts down stem-cell regeneration, then immunity, then the organs.
The 62% figure is roughly correct if you count atoms, because water is two-thirds hydrogen atoms. By weight, hydrogen is about a tenth of the body. Those hydrogen atoms arrive constantly in water and food, and no one runs short of them. Molecular hydrogen gas (H₂), the therapeutic agent, is a different thing. The body uses it as a signaling and antioxidant molecule, not as a building material. Healthy gut bacteria already produce it in quantity: researchers estimate up to about a liter of hydrogen a day, much of it absorbed and exhaled through the lungs. I know of no clinical syndrome of “hydrogen deficiency” in the medical literature. The idea is interesting enough to test — hydrogen breath tests already exist — but it should not be presented as an established cause of disease.
“Only 1% is needed; the rest is exhaled”
Wiseman says that 1–2% hydrogen in the inhaled air saturates the blood at about 1.6 parts per million, and that anything more is simply exhaled. The safety conclusion is sound: keep the inhaled mixture near 2%, well below hydrogen’s 4% flammability limit in air. The physiology behind it is not.
Hydrogen dissolves in blood in proportion to how much is in the air you breathe (Henry’s law). The figure of 1.6 parts per million is what water holds when exposed to pure hydrogen at one atmosphere. Breathing 2% hydrogen yields roughly a fiftieth of that. Rat studies measuring tissue hydrogen directly found that tissue levels rise steadily with the inhaled concentration; there is no ceiling at 1%. Wiseman’s practical number happens to be reasonable, though. In the original rat stroke study, 2% hydrogen protected better than either 1% or 4%, and HYBRID II used 2%. So his dose is defensible, even though his explanation for it is not.
“Zero toxicity, zero side effects”
Hydrogen itself has an excellent safety record across dozens of human trials. The machine is another matter. A Brown’s Gas generator makes a detonable mixture of two parts hydrogen to one part oxygen, and that mixture fills the cell, the bubbler, and the tubing all the way to the nostrils. It becomes safe only after it mixes with room air at the nose. Wiseman knows this better than anyone: he told the audience that the loudest explosion he ever heard came from a Brown’s Gas test chamber. Hospital devices that deliver the same 66/33 mixture are engineered around this hazard.
A patient using one at home should observe the precautions of oxygen therapy and then some: no smoking, candles, gas stoves, or open flame nearby; no static-prone bedding near the tubing; and a working water bubbler or flashback arrester between the cell and the cannula. “Zero side effects” may be true of the hydrogen. It is not a safe description of the apparatus.
Deuterium-depleted water from the torch
Wiseman says that burning Brown’s Gas and condensing the steam produces deuterium-depleted water, saving people hundreds of dollars a month. The first part is correct: electrolysis splits ordinary water preferentially, so the first gas from a fresh cell is lighter in deuterium. But the deuterium that is left behind accumulates in the electrolyte. In a cell that is continuously topped up, the electrolyte becomes enriched until the gas leaving it carries the same deuterium ratio as the water going in. Heavy-water engineers rely on exactly this behavior. Wiseman’s own manual noted that heavy water builds up in an electrolysis cell. A home unit in steady use will not make deuterium-depleted water unless its electrolyte is periodically discarded and replaced, and the result should be confirmed by isotope analysis before anyone pays for it as a therapy.
The Cancer Claims
This is the part of the interview I most want to answer, because it is where a reader can be harmed.
Wiseman described two cases. In the first, a customer in 1996 taped a cotton ball soaked in Brown’s Gas water over a melanoma on his forehead, and in three weeks the skin looked completely normal. In the second, a 26-year-old woman with breast cancer that had spread to her spine declined surgery, chemotherapy, and radiation, used only Brown’s Gas, and was reported cancer-free a year later.
Following my own standard, I treat firsthand reports as leads, not as falsehoods. But I need to say plainly what these leads can and cannot show.
A melanoma that disappears from the surface of the skin has not necessarily disappeared. Melanoma is known for regressing at the surface while cells persist deeper in the skin or have already spread to lymph nodes. That is why a pigmented lesion that changes, or that seems to vanish, must be biopsied and, if it is melanoma, excised with proper margins. Normal-looking skin three weeks later is not a pathology report. For melanoma, the difference between excision and observation can be the difference between a minor procedure and a fatal disease.
The breast cancer case cannot be evaluated without the imaging, pathology, and follow-up. Was the spinal lesion biopsied? What did the follow-up scans show, and who read them? How long has she been followed since? Breast cancer that has spread to bone can sometimes be held in check for years with treatment, and it can also progress silently. A case like this deserves to be documented and published, because if it holds up it would be important. As it stands, it is a story.
So here is my advice to a patient who asks. Use hydrogen if you like; the evidence for safety is good, and the evidence for quality-of-life benefit in cancer is suggestive. Use it alongside properly diagnosed and properly monitored care, never as a reason to skip a biopsy or to refuse a treatment with known curative power. Choosing among treatments is the patient’s right, and he should make that choice with the facts in front of him, not on the strength of testimonials offered by the seller of the device.
Other Claims in the Interview
Several non-medical claims in the interview deserve a brief answer, because they bear on how much weight to give the rest.
- Over-unity heat. Wiseman told the audience that a pure-water heater on household current runs at about 130% efficiency. His own measurements in the book came to 96% of the electrical input. That is a fine water heater, but it is not over-unity.
- “New water” that transmutes. He described a bottle of condensed torch water that grew six ounces of sediment containing all fifty minerals of a supplement bottle that stood next to it in the sunlight, and another bottle that came to taste like the orange juice beside it in the refrigerator. The orange-juice case has a well-known explanation: the aromatic compounds of citrus, chiefly limonene, pass through plastic bottle walls, and plastic-bottled water readily picks up flavors from nearby food. The sediment claim calls for a controlled test, and Adams offered one on the air with his mass spectrometer. That test should include sealed glass bottles, a blank control, and the supplement bottle analyzed alongside. Until then, contamination is the ordinary explanation.
- Plants growing three to ten times faster, ore yielding three times the metal, fuel savers doubling mileage. Each of these could be tested side by side with controls, and none of them came with data in the interview.
- Suppression. Secrecy orders under the Invention Secrecy Act of 1951 are real, and their contents are not public. So no one can say from the outside what they cover. The existence of suppression in some cases does not establish that any particular device works.
None of this disproves the medical claims. But it tells us how the claims in this interview were formed. They come from a gifted builder who tests ideas in his shop and then reports what he saw, often without the controls that would separate what he saw from what caused it. That is how invention begins. It is not where medicine can stop.
Why the Hope Remains Plausible
I have been critical of particulars. The larger hope behind them — that a simple, cheap gas made from water might help the body heal — is not foolish, and I want to give it its strongest form.
First, the mechanism is real. Oxidative and inflammatory injury drives a great deal of chronic disease, and hydrogen’s selective quenching of the most damaging radicals is published, reproduced, and plausible. A therapy acting on a common pathway would be expected to help many unrelated conditions a little. That is exactly the pattern of the testimonials, and it is also the pattern that makes testimonials hard to sort out.
Second, the money runs the wrong way for proof. Hydrogen cannot be patented. No company will spend the hundreds of millions of dollars a large Western trial costs on a gas anyone can make from water. The research is being done in Japan and China, where hospitals and governments have taken it up, and in small trials funded by device makers. The absence of large trials reflects the economics more than the science.
Third, the safety margin is wide. A therapy that is cheap, low in toxicity, and plausible in mechanism is a reasonable thing for a patient to try, as long as it does not displace something better. That qualification is the whole of my disagreement with the interview.
Fourth, the institutions have earned suspicion. Mike Adams framed the conversation around engineered scarcity and a pharmaceutical industry that profits from sickness. I do not share every part of that framing, but the underlying observation is fair. Medicine has historically been slow to study what it cannot sell, and patients have been right to look elsewhere when the mainstream had nothing to offer them.
“Prove all things; hold fast that which is good.” (1 Thessalonians 5:21) Hydrogen therapy has earned a place on the list of things worth proving. It has not yet earned a place among the things we hold fast as cures.
Evidence, Graded by Kind
- Supported by controlled human trials (small, early): hydrogen inhalation is safe; it improved survival and functional recovery after cardiac arrest in one randomized trial; it improved respiratory symptoms in COVID-19 and COPD studies.
- Tested and not supported: hydrogen water or inhalation for slowing Parkinson’s disease.
- Uncontrolled observational data: quality-of-life and tumor-marker improvement in advanced cancer.
- Firsthand reports (leads, unverified): Wiseman’s own recovery, the lupus testimonial, the melanoma and breast cancer cases, rapid healing of sprains, scars, carpal tunnel pain, and wounds.
- Claims contradicted by measurement or basic physics: the “1% saturates the blood” ceiling; over-unity heat from his own book’s data; deuterium-depleted water from a steadily topped-up cell.
- Asserted without published evidence: electrically expanded water, its 30% therapeutic advantage, the threefold EZ-water expansion, and “hydrogen deficiency” as a cause of disease.
Sources and Their Limits
The claims I respond to come from George Wiseman’s interview on Decentralize TV with Mike Adams and Todd Pittner, together with his book Brown’s Gas, Book One. Both the guest and the host have commercial interests: Wiseman sells the AquaCure machine at about $3,000, and the program arranged a donation program tied to sales. I checked the medical claims against Ohsawa and colleagues in Nature Medicine (2007) and later reviews of hydrogen medicine; the HYBRID II trial in eClinicalMedicine (2023); the Chinese COVID-19 hydrogen-oxygen trial and its registration; the Yoritaka Parkinson’s trials (2018 and 2021); the Chen and Xu cancer reports in Medical Gas Research (2019); systematic reviews in Molecules (2023) and the International Journal of Molecular Sciences (2024); rat tissue-concentration studies; recent gut-microbiome research on hydrogen production in Nature Microbiology (2025); heavy-water electrolysis patents; and a critical review of exclusion-zone research (2020).
This sourcing leans on the published, peer-reviewed record, and that record is thin where the commercial incentive is weak. Hydrogen research is concentrated in Japan and China and is partly funded by device makers. Wiseman’s customer testimonials, his unpublished work with the University of Washington, and the wider community of home users are not in the journals at all, and I did not examine them. If case records exist for the cancer recoveries he described — biopsy reports, scans, and follow-up — they are exactly the evidence that could change my assessment, and I would gladly review them.